Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases

Brain : a Journal of Neurology
N BiroukP Bouche

Abstract

A clinical and electrophysiological study was performed in 119 Type 1A Charcot-Marie-Tooth disease (CMT1A) patients with proven 17p11.2 duplication. Onset of the first functional manifestations was in the first decade in 50% of cases and before the age of 20 years in 70% of cases. The predominant clinical signs were muscle weakness and wasting in the lower limbs. None of the patients was normal on clinical examination and all presented at least pes cavus or ankle jerk areflexia. Motor nerve conduction velocity (MNCV) was uniformly reduced in all nerves, and was < or = 33 m/s in the median nerve for all patients. Sensory potentials were abnormal in all cases, even where there was no clinical sensory loss. Needle electromyography recruitment was reduced in distal muscles for all patients. MNCV slowing was fully consistent with the presence of duplication even in clinically asymptomatic individuals or in children, confirming the complete electrophysiological penetrance of 17p11.2 duplication and making median nerve MNCV a reliable tool for screening affected at-risk individuals. Functional disability was mild. Ninety-six percent of patients were autonomous; 25% were asymptomatic and diagnosed by systematic family investigation esp...Continue Reading

Citations

Jul 22, 1998·Microscopy Research and Technique·R Naef, U Suter
Aug 3, 2000·Muscle & Nerve·M Auer-GrumbachH P Hartung
Sep 24, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·C JunquéJ M Mercader
Sep 6, 2007·European Biophysics Journal : EBJ·Diana Stephanova, Mariya Daskalova
Mar 15, 2005·Journal of Neurology·Wilson MarquesAmilton A Barreira
Aug 31, 2006·Journal of Neurology·Henriette M E BienfaitMarianne de Visser
Oct 31, 2006·Biological cybernetics·D I StephanovaL Christova
Jan 25, 2012·Neurogenetics·Tomonori NakamuraHiroshi Takashima
Aug 3, 2007·Nature Clinical Practice. Neurology·Klaus-Armin NaveHannelore Ehrenreich
May 1, 2001·The European Journal of Neuroscience·J C NorreelF Clarac
May 4, 2012·British Medical Bulletin·Robert FledrichMichael W Sereda
Dec 1, 2003·Journal of Clinical Neuromuscular Disease·Safwan S Jaradeh
Nov 5, 2011·Journal of Paediatrics and Child Health·Manoj P Menezes, Kathryn N North
May 7, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J P van DijkM J Zwarts
Jan 25, 2008·Annals of Human Genetics·N BarisicV Timmerman
Nov 24, 2005·Epilepsia·Sylvain RheimsPhilippe Ryvlin
Dec 10, 1999·Annals of the New York Academy of Sciences·P K Thomas
Dec 10, 1999·Annals of the New York Academy of Sciences·A Gabreëls-Festen, R V Wetering
Dec 10, 1999·Annals of the New York Academy of Sciences·M Auer-GrumbachH P Hartung
Nov 18, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·M DonaghyC Bell
Jan 25, 2007·Journal of Integrative Neuroscience·D I Stephanova, A S Alexandrov
Jun 19, 2009·BMC Neuroscience·Junji ItouTakashi Kawasaki
Jul 1, 2008·Experimental & Molecular Medicine·Ki Wha ChungByung-Ok Choi
Feb 15, 2014·BMC Anesthesiology·Hubert J SchmittTino Münster
Aug 6, 2011·Journal of the American Podiatric Medical Association·Htet Htet Ne WinDiarmuid Smith
Jan 13, 2005·Journal of Neurology·Camiel VerhammeMarianne de Visser
Sep 14, 2014·Brain : a Journal of Neurology·Janina HantkeKristján R Jessen
Sep 7, 2007·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Nizar ChahinP James B Dyck

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.